Everand Logo

Welcome to Everand!

  • STAT

    How the drug industry keeps winning in Washington

    An insider's guide to the politics and policy of health care.
    by Nicholas Florko Jul 16, 2019 4 minutes

    D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

    How the drug industry keeps winning

    What if I told you the Sen. Thom Tillis campaign account was graced with nearly $20,000 in personal donations from drug industry CEOs and other top industry brass on Valentine’s Day? You’d think it was some cheesy made-for-TV movie about D.C.’s power elite, right? Well, it’s not: It’s just one of the many salacious details Lev and I dug up while reporting a big new story about how, despite all the inflammatory rhetoric, the drug industry

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
    Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

    Related Books & Audiobooks